Human Immunodefi ciency Virus (HIV)infection represents one of the most serious challenges to global public health, since more than 30 million people are living with HIV/AIDS worldwide. Highly active antiretroviral treatment (HAART) introduction has dramatically changed the mortality and morbidity of HIV-affected subjects in industrialized countries but has implied an evolution of many HIV-related aspects, both in the utilisation of new antiretroviral drugs options and in the newly-observed spectrum of HIV-associated diseases, including the rheumatic pathology. Current epidemiological, therapeutic, autoimmune and rheumatic aspects of HIV-1 infection are here discussed.
HIV/AIDS : epidemic update, new treatment strategies and impact on autoimmunity / F. Croce, S. Piconi, F. Atzeni, P. Sarzi-Puttini, M. Galli, M. Clerici. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 26:1 suppl. 48(2008 Jan), pp. S48-S52.
HIV/AIDS : epidemic update, new treatment strategies and impact on autoimmunity
F. CrocePrimo
;S. PiconiSecondo
;P. Sarzi-Puttini;M. GalliPenultimo
;M. ClericiUltimo
2008
Abstract
Human Immunodefi ciency Virus (HIV)infection represents one of the most serious challenges to global public health, since more than 30 million people are living with HIV/AIDS worldwide. Highly active antiretroviral treatment (HAART) introduction has dramatically changed the mortality and morbidity of HIV-affected subjects in industrialized countries but has implied an evolution of many HIV-related aspects, both in the utilisation of new antiretroviral drugs options and in the newly-observed spectrum of HIV-associated diseases, including the rheumatic pathology. Current epidemiological, therapeutic, autoimmune and rheumatic aspects of HIV-1 infection are here discussed.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.